Pacira BioSciences, Inc. (PCRX) short interest & options flow
NASDAQPCRX cost to
Full pulse commentary is for ORTEX subscribers. The live data picture for PCRX below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for PCRX are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
- Market cap
- $1.45B
- Next earnings
- 6 Nov 2026
Key data as of 4 Nov 2026
Latest signals on PCRX
- Cost to Borrow
PCRX cost to
- Short Interest
PCRX short interest collapses 48.5% in a week to 8.7% of float, as cost to borrow surges to 2.38%, up 336% from last week.
- Analyst
PCRX short interest climbs to 18% of free float, up 5.8% over one month, as Truist downgrades to Hold while raising price target to $36.50 from $31.
5 Analyst updates in 30 days
PCRX news and analysis
RSSNo long-form analysis yet for PCRX. Pulse alerts and the live data picture are available on ORTEX.
Open PCRX on ORTEX →Want the live picture for PCRX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PCRX — free to start on ORTEX.
Sign up for free →Open PCRX on ORTEX